Internal Medicine Interventional Cardiology
Resume:
Curriculum Vitae
Stephen James Mattichak, MD,
FACC, FSCAI, SVM
Home Address: **** ******** *****
Midland, MI 48640
Contact Information: **********@*****.***
Board Certifications: American Board of Internal Medicine
Internal Medicine 2000
American Board of Internal Medicine
Cardiovascular Disease 2005
Recertification Cardiovascular Disease 2015
Participating in ABIM MOC and CMP
American Board of Internal Medicine
Interventional Cardiology 2006
Recertification Interventional Cardiology 2016
Participating in ABIM MOC and CMP
Work History: MyMichigan Healthcare
MyMichigan Interventional Cardiology
2660 Sugnet Road
Midland, MI 48670
May 15, 2023 to current
Director, Becky Boyce
McLaren Medical Group
McLaren Northern Michigan
Interventional Cardiology and Vascular Medicine
560 W. Mitchell St
Petoskey, MI 49770
August 1, 2022 to May 6, 2023
Paragon Cardiology Consulting
CEO/Owner/Independent Contractor
5602 Pondview Drive
Midland, MI 48640
September 1, 2021 to Current
McLaren Medical Group
McLaren Northern Michigan
Interventional Cardiology and Vascular Medicine/Endovascular
560 W. Mitchell St
Petoskey, Michigan 49770
September 1, 2020 to September 3, 2021
Comphealth
Locum Tenens Interventional Cardiology
Sanford, Bemidji
Bemidji, MN
April 2022 thru August 2022
CompHealth
Locum Tenens Interventional Cardiology
Bay Area Hospital
Coos Bay, OR
May 2020 thru August 2020;
September 2021 thru August 2022
Vascular Health Clinics
Interventional Cardiology and Endovascular Peripheral
2125 Ridgewood Drive
Midland, MI 48642
989-CLINICS
December 1, 2017 to August 1, 2020
Gap from Flint Cardiology Consultants for Insurance credentialing
Delta Locums
Locum Tenens Interventional Cardiology
Centura Mercy Hospital
Durango, CO
September thru December 2019
Flint Cardiovascular Consultants
Interventional Cardiology
4455 Town Center Parkway
Flint, MI 48532
October 14, 2016 to October 22, 2017
McLaren Medical Group
McLaren Bay Heart and Vascular
Bay Regional Medical Center d/b/a McLaren Bay Region
January 2009 to October 12, 2016
Michigan Cardiovascular Institute, Saginaw, MI
Interventional Cardiology and Clinical Cardiology
August 2006 to January 2009
IPC, The Hospitalist Company
Internal Medicine/Hospitalist Medicine
July 2000 thru December 2001
St. Louis, MO
Licensure: US DEA License for medical practice, State of Michigan
US DEA License for locum assignment-transferrable
Physician, State of Michigan Medical Board
Physician, Interstate Medical License Compact, Qualification Active thru February 2024
Physician, State of Utah Medical Board
Physician, State of Colorado Medical Board
Physician, State of Ohio Medical Board
Physician, State of Kentucky Medical Board
Physician, State of Minnesota Medical Board
Physician, State of Oregon Medical Board-Locum License
Michigan State Board of Pharmacy
Education: Doctor of Medicine 7/1993-6/1997
Wayne State University School of Medicine
Detroit, Michigan
Bachelor of Arts 8/1989-6/1993
Graduate, Albion College Honors Program
Graduate, Gerald R. Ford Institute for Public Service
Graduate Medical Education:
Interventional Cardiology Fellowship 7/2005-6/2006
William Beaumont Hospital
Royal Oak, Michigan
Adult Clinical Cardiology Fellowship 7/2002-6/2005
William Beaumont Hospital
Royal Oak, Michigan
Internal Medicine-Categorical Training 7/1997-6/2000
Emory University School of Medicine
Atlanta, Georgia
Hospital Affiliations: MyMichigan Medical Center, Midland, Michigan
Active Staff
McLaren Northern Michigan, Petoskey, Michigan
Active Staff
Sanford Healthcare, Bemidji, MN
Active Staff
Marlette Regional Hospital, Marlette, MI
Consulting Staff
Professional Societies: American Collge of Cardiology FACC
Society of Cardiac Angiography and Intervention FSCAI
Society of Vascular Medicine
Michigan State Medical Society
Procedural Volume: Over 16 years of interventional cardiology practice:
Proficiencies: Over 100 PCI annual
Protected PCI/High Risk PCI, Primary and Rescue PCI
CTO Coronary and peripheral
Coronary IVL Shockwave, Peripheral IVL Shockwave
Rotablator/Orbital atherectomy
Laser ELCA Phillips, 0.9 mm/1.4 mm Coronary, Peripheral laser
IVUS/OCT
iFR/RFR
Radial and Femoral Interventional Competency
IABP
Impella CP single and multisite access
R Pella insertion for RV shock
ASD and PFO closure for CVA/Shunt
Gore Cardioform proficient with over 35 implants
Vascular medicine and Vascular Non-invasive
Peripheral Diagnostic and Endovascular Interventions
Laser, directional atherectomy, angioplasty, IVL, stenting
Pedal and RP, conventional femoral
PERT Team, Inari/Penumbra/Ekos
DVT Inari/Penumbra
May Thurner
Loop Recorder Implant and Explant
Echocardiogram and TEE
Stress ECG/Stress Echocardiogram/Nuclear Stress
BLS/ACLS Certification
Appointments: Associate Professor, MSU School of Medicine
June 2023 to current
Associate Professor, CMU School of Medicine
June 2023 to current
Coordinator, Regional STEMI Network MyMichigan Health
Chief, Division of Cardiology
Bay Regional Medical Center d/b/a McLaren Bay Region
2010-2012, 2015-2017
Vice Chief, Division of Cardiology,
Bay Regional Medical Center 2008-2010
Co-Medical Director, Echocardiography Laboratory
Bay Regional Medical Center
2008 thru Present
Co-Director, Cardiovascular Research,
Bay Regional Heart and Vascular
Institutional Review Board, 2010-2011
Bay Regional Medical Center
Pharmacy and Therapeutics Committee, Bay Regional Medical Center
Clinical Research: Target FireHawk Stent study
Subinvestigator
McLaren Northern Michigan 2022- ongoing
Zeus Study
Subinvestigator
McLaren Northern Michigan 2022- ongoing
Institutional Principal Investigator, Cogentis Pharmaceutical
Randomized study of clopidogrel versus clopidogrel and omeprazole. Bay Regional Medical Center. (2007-2008)
Sub-Investigator, Sapphire WW, Carotid Stent Registry,
Bay Regional Medical Center. (2007-2008)
Sub-Investigator, Amethyst, Medtronic, Embolic Protection for saphenous vein graft intervention. Bay Regional Medical Center. (2007-2008).
Sub-Investigator, Spirit IV, Abbott Vascular, randomized study of
drug eluting Xience V versus Taxus, Bay Regional Medical Center. (2007-2008).
Sub-Investigator, Tracer, randomized study of complement inhibitor in acute coronary syndrome, Bay Regional Medical Center (2008-2009).
Sub-Investigator, Ascend-HF, randomized study of Natrecor versus loop diuretic for treatment of decompensated heart failure,
Bay Regional Medical Center (2007-2008).
Sub-Investigator, ALECARDIO, Cardiovascular outcomes study to evaluate the potential of aleglitazar to reduce cardiovascular risk in patients with a recent acute coronary (ACS) event and type 2 diabetes mellitus (T2D), McLaren Bay Region, (2010-2014).
Sub-Investigator, ALERTS, AngeLmed for Early Recognition and Treatment of STEMI Study, Angel Medical Systems, McLaren Bay Region (2012-Present).
Sub-Investigator, CHOICE, Carotid Stenting For High Surgical Risk Patients; Evaluating Outcomes Through The Collection Of
Clinical Evidence, Abbott Vascular, Bay Regional Medical Center, 2009-2012.
Sub-Investigator, HCRI-DAPT, A Prospective, multi-center, randomized, double-blind, trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy (DAPT) in subjects undergoing percutaneous coronary intervention (PCI) with either drug-eluting stent (DES) or bare metal stent (BMS) placement for the treatment of coronary artery lesions. Harvard Clinical Research Institute, Bay Regional Medical Center (2009-Present).
Sub-Investigator, ORBIT-AF, Outcomes Registry for Better Informed Treatment of Atrial Fibrillation, Johnson and Johnson, McLaren Bay Region, (2010-present).
Sub-Investigator, RESOLUTE, A Clinical Evaluation of the Medtronic Endeavor Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of DE NOVO Native Lesions in Native Coronary Arteries with a Reference Vessel Diameter of 2.25mm to 4.2mm Medtronic, Bay Regional Medical Center (2009-Present)
Sub-Investigator, SELECT-ACS, A Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Efficacy and Safety of 2 Doses of RO4905417 (R1512) Administered to Patients with Non ST-Elevation Myocardial Infarction (Non-STEMI) undergoing Percutaneous Coronary Intervention (PCI),
Roche, Bay Regional Medical Center, (2011-2012).
Sub-Investigator, SPIRIT PRIME, A Clinical Evaluation of the XIENCE PRIME™ and XIENCE PRIME™ LL Everolimus Eluting Coronary Stent System. Abbott Vascular, McLaren Bay Region. (2009-2013)
Sub-Investigator, TRANSLATE-ACS, Observational Study Description H7T-US-B007(1) - Treatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome, Lilly, McLaren Bay Region, (2011-2014).
Sub-Investigator, TRILOGY ACS, A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome (ACS) Subjects with Unstable Angina/Non-ST-Elevation Myocardial Infarction (UA/NSTEMI) Who are Medically Managed. Eli-Lilly, McLaren Bay Region (2009-2012)
Sub-Investigator, XIENCE V USA, a prospective, open-label, multi-center, observational, single arm registry to evaluate XIENCE V EECSS continued safety and effectiveness during commercial use in real world settings. Abbott Vascular, McLaren Bay Region (2008-2013)
Sub-Investigator, XIENCE V USA DAPT, A prospective, multi-center, randomized, double-blind AV-DAPT cohort to assess the effectiveness and safety of 12 versus 30 months of DAPT in patients undergoing percutaneous coronary intervention (PCI) with XIENCE V placement for the treatment of coronary artery lesions. Abbott Vascular, McLaren Bay Region (2009-2013)
Sub-Investigator, ABSORB III RCT, A Clinical Evaluation of Absorb™ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects with de novo Native Coronary Artery Lesions. Abbott Vascular, McLaren Bay Region, (2013-Present).
Sub-Investigator, GLAGOV, A Double-Blind, Randomized, Multi-center, Placebo-controlled, Parallel-group Study to Determine the Effects of Evolocumab (AMG-145) Treatment on Atherosclerotic Disease Burden as Measured by Intravascular Ultrasound in Subjects Undergoing Coronary Catheterization. Amgen, McLaren Bay Region (2013-Present)
Sub-Investigator, GLORIA-AF, Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients with Atrial Fibrillation.
Boehringer Ingelheim, McLaren Bay Region (2012-Present).
Sub-Investigator, GRAND_306, A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate Cardiovascular Outcomes of TAK-875, 50 mg in Addition to Standard of Care in Subjects with Type 2 Diabetes and with Cardiovascular Disease or Multiple Risk Factors for Cardiovascular Events. Takeda, McLaren Bay Region (2012-2014).
Sub-Investigator, MACE, Multi-center Prospective Study to Evaluate Outcomes of Moderate to Severely Calcified Coronary Lesions, Cardiovascular Systems Inc, McLaren Bay Region (2013-Present).
Sub-Investigator, ORBIT-AF II, Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II, Janssen Scientific Affairs, McLaren Bay Region (2013-Present).
Sub-Investigator, REGULATE-PCI, A Randomized, Open-label, Multi-center, Active-controlled, Parallel Group Study to Determine the Efficacy and Safety of the REG1 Anticoagulation System compared to Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention, Regado Biosciences, McLaren Bay Region (2013-Present).
Publications: Mattichak SJ, Dixon SR, Shannon F, Boura JA, Safian RD, Failed percutaneous coronary intervention: A decade of experience in 21,000 patients. Catheterization and Cardiovascular Interventions 71:2, 2008
Mattichak SJ, Dixon SR, Safian RD, Hanzel GS, Boura JA, O’Neill WW, Eligibility for use of proximal or distal embolic protection devices during percutaneous intervention for acute myocardial infarction, Journal of Interventional Cardiology 18:4, 2005.
Mattichak SJ, Harjai KJ, Dutcher JR, Boura JA, Stone G, Brodie BR, O’Neill WW, Grine CL, Left ventricular remodeling and systolic deterioration in acute myocardial infarction: Finding of the Stent-PAMI study, Journal of Interventional Cardiology 18:4, 2005.
Mattichak SJ, Reed PS, Kahn JK, O’Neill WW, Evaluation and safety of warfarin in combination with antiplatelet therapy for patients with coronary stents after acute myocardial infarction, Journal of Interventional Cardiology, 2004.
Contact this candidate